Emtricitabine

Basic Information

CAS ID: 143491-57-0
Molecular Formula: C8H10FN3O3S
Molecular Weight: 247.3 g/mol
Monoisotopic Mass: 247.0427 g/mol
Class: Small Molecule
Natural Product: No
Other Names: FTC-(-) | EMTRIVA | FTC | 524W91 | (-)-FTC | BW-524W91 | EMTRICITABINE
Analysis: Drug repositioning mechanism analysis

H2N N O N F S OH O

Compound Structure and Identifier

InChI: InChI=1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5-,6+/m0/s1 See All
InChI Key: XQSPYNMVSIKCOC-NTSWFWBYSA-N
Smiles: NC1=NC(=O)N(C=C1F)[C@@H]2CS[C@H](CO)O2 See All
Molfile: Download

Related Target

Related Fibrosis Property

Trial Record 1

ClinicalTrial ID NCT02327689 Disease Liver fibrosis
Phase Phase 4 Status Unknown
First Received December 30, 2014 Last Verified December 30, 2014
Sponsor Asian-Pacific Alliance of Liver Disease, Beijing

Trial Record 2

ClinicalTrial ID NCT01529749 Disease Liver fibrosis
Phase Phase 4 Status Completed
First Received February 9, 2012 Last Verified February 19, 2016
Sponsor Felipe Garcia

Trial Record 3

ClinicalTrial ID NCT01614405 Disease Liver fibrosis
Phase Not Applicable Status Completed
First Received June 7, 2012 Last Verified December 2, 2015
Sponsor University of Alberta

Trial Record 4

ClinicalTrial ID NCT01908660 Disease Liver fibrosis
Phase Status Completed
First Received July 26, 2013 Last Verified November 11, 2015
Sponsor Valme University Hospital

Related Link

PubChem: 60877
ChEMBL: CHEMBL885